Chronic diseases to fuel $6.3b medical imaging software boom

Data quality and diversity will pose a challenge to the market.

The global medical image analysis software market is projected to grow to $6.3b by 2031, driven by rising volumes of CT, MRI, X-ray, ultrasound, and mammography procedures.

According to a Wissen Research report, the growing cancer, cardiovascular disease, and neurological conditions require repeated, precise imaging-based assessment.

Bringing AI-based image analysis tools into standard clinical use requires them to demonstrate efficiency, dependability, and medical usefulness, a process that involves substantial regulatory and validation work before deployment.

However, data quality and diversity challenge the market, since models trained on limited datasets can behave unpredictably across different patient populations, imaging equipment, and healthcare settings.

Regionally, North America leads the market, supported by its high imaging volumes, healthcare infrastructure, and the presence of major imaging and healthcare software companies.

Meanwhile, Asia-Pacific is the fastest-growing region, driven by healthcare spending, diagnostic infrastructure, and access to advanced imaging equipment across China, Japan, India, South Korea, and Australia.

The digitalisation of healthcare, cancer and cardiovascular disease, and private hospitals' expansion also support regional adoption.